What is Leerink Partnrs’ Forecast for ZNTL Q3 Earnings?
Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...
Brokers Set Expectations for Zoetis’ Q1 Earnings (NYSE:ZTS)
Analysts at Leerink Partnrs decreased their Q1 2025 earnings per share (EPS) estimates for shares of Zoetis in a research ...
Investment Banker Cleared to Seek Multi-Million Bonuses Against Former Boston Employer
U.S. District Judge Angel Kelley for the District of Massachusetts allowed state law claims to move forward in a suit brought by an investment banker who claims Leerink Partners failed to pay minimum ...
CVS Health's turnaround efforts in focus amid record-high medical costs
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Leerink lifts Inspire Medical stock target to $194, maintains rating
Leerink Partners made a slight adjustment to the price target of Inspire Medical Systems (NYSE:INSP), raising it from $193.00 to $194.00, while keeping a Market Perform rating on the stock. According ...
BioSpace19h
Vertex Eyes Expansive, Easy Access for Journavx in Coming Weeks
Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...